Omeros Corp., of Seattle, said it closed the registered direct offering of 3.9 million shares of common stock priced at $4.14 per share, raising net proceeds of about $16.1 million

Under the terms of its financing deal, Dyax priced a total of 8.9 million shares of common stock and 41,418 shares of Series 1 convertible preferred stock...MediciNova Inc., of San Diego, entered a securities purchase agreement, selling about 1.2 million shares of common stock priced at $3.15 apiece

Discovery Laboratories Inc., of Warrington, Pa., said it priced a $14.25 million public offering of 9.5 million shares of common stock at $1.50, an 8.5 percent discount to Thursday's closing price

In its filing, Isis said it would have 111.7 million shares of common stock outstanding when the offering closes

Receptos Inc., of San Diego, priced its initial public offering (IPO) of 5.2 million shares of common stock at $14 per share, for a total raise of $72.8 million

The increase is primarily due to proceeds of approximately $352 million received from a public offering of 4.4 million shares of common stock, completed in January

Idera Pharmaceuticals Inc., of Cambridge, Mass., closed its previously announced $16.5 million underwritten public offering of 17.5 million shares of common stock and related warrants to purchase up to 17.5 million more shares of common stock at an exercise price of 47 cents per share, and pre-funded warrants to purchase up to about 15.8 million shares of common stock at an exercise price of 1 cent per share and related warrants to purchase up to the same number of shares of common stock at an

to sell shares of common stock 4/19/13 Navidea Biopharma-ceuticals Inc. (Dublin, Ohio) At-the-market common stock offering 2.1S $5.1 Navidea raised $5.1M in an offering of 2.1M shares at $2.43 per share

1 million shares of common stock, with underwriters exercising their overallotment option in full, purchasing an additional 469,483 shares

Warrants to purchase 0.28 shares of common stock were issued for each share of common stock purchased...An additional 1,923,599 shares of common stock and corresponding warrants were issued at the final closing to certain existing stockholders of the company who participated in earlier closings of this financing

The company plans to issue approximately 14.3 million shares of common stock and 9,900 shares of Series B convertible preferred stock at closing, expected on or about May 3

26, 2017, at an interest rate of 13 percent, and the conversion rate will be re-priced from $3.78 to $1.25 per share of common stock

The securities were sold as a unit, at 48 cents each, consisting of one share of common stock and 0.40 of a warrant to purchase one share of common stock

Navidea Biopharmaceuticals Inc., of Dublin, Ohio, priced its at-the market sale of 2.1 million shares of common stock at $2.43 per share, raising gross proceeds of $5.1 million

AMC approval is one of the conditions for consummation of its tender offer for all outstanding shares of common stock in Obagi at $24 per share

During the first quarter, Amgen repurchased about 9 million shares of common stock, settled $2.5 billion of 0.375 percent convertible senior notes and declared a $0.47 per share dividend for the second quarter

Each unit consists of one share of common stock and 0.4 of a warrant to purchase one share, with an exercise price of 53 cents per share

Regulus also received $5 million from the sale of a convertible note in August 2012 to Biogen Idec Inc., one of its research collaborators, which converted into shares of common stock at the completion of the IPO

MediciNova Inc., of San Diego, said in an SEC filing that it entered an equity distribution agreement with Macquarie Capital Inc. (MCUS) to sell shares of common stock up to an aggregate of $6 million from time to time, through MCUS as sales agent